| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mast cells that are in close proximity to autonomic and enteric nerves release several mediators that cause neuronal hyperexcitability. This study examined whether mast cell tryptase evokes acute and long-term hyperexcitability in submucosal neurons from the guinea-pig ileum by activating proteinase-activated receptor 2 (PAR2) on these neurons. We detected the expression of PAR2 in the submucosal plexus using RT-PCR. Most submucosal neurons displayed PAR2 immunoreactivity, including those colocalizing VIP. Brief (minutes) application of selective PAR2 agonists, including trypsin, the activating peptide SL-NH2 and mast cell tryptase, evoked depolarizations of the submucosal neurons, as measured with intracellular recording techniques. The membrane potential returned to resting values following washout of agonists, but most neurons were hyperexcitable for the duration of recordings (> 30 min-hours) and exhibited an increased input resistance and amplitude of fast EPSPs. Trypsin, in the presence of soybean trypsin inhibitor, and the reverse sequence of the activating peptide (LR-NH2) had no effect on neuronal membrane potential or long-term excitability. Degranulation of mast cells in the presence of antagonists of established excitatory mast cell mediators (histamine, 5-HT, prostaglandins) also caused depolarization, and following washout of antigen, long-term excitation was observed. Mast cell degranulation resulted in the release of proteases, which desensitized neurons to other agonists of PAR2. Our results suggest that proteases from degranulated mast cells cleave PAR2 on submucosal neurons to cause acute and long-term hyperexcitability. This signalling pathway between immune cells and neurons is a previously unrecognized mechanism that could contribute to chronic alterations in visceral function.
This article has been cited by other articles:
|
|
 |
|
  W. E. B. Sipe, S. M. Brierley, C. M. Martin, B. D. Phillis, F. B. Cruz, E. F. Grady, W. Liedtke, D. M. Cohen, S. Vanner, L. A. Blackshaw, et al. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1288 - G1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Metzger, U. Rolle, H. C Fiegel, F. E Franke, K. Muenstedt, and H. Till C-kit receptor in the human vas deferens: distinction of mast cells, interstitial cells and interepithelial cells Reproduction, March 1, 2008; 135(3): 377 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, M. Kollarik, A. Ouyang, A. C. Myers, and B. J. Undem Mast cell-mediated long-lasting increases in excitability of vagal C fibers in guinea pig esophagus Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G850 - G856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Roka, A. Ait-Belgnaoui, C. Salvador-Cartier, R. Garcia-Villar, J. Fioramonti, H. Eutamene, and L. Bueno Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats Gut, August 1, 2007; 56(8): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kayssi, S. Amadesi, F. Bautista, N. W. Bunnett, and S. Vanner Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon J. Physiol., May 1, 2007; 580(3): 977 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Vergnolle CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT Gut, June 1, 2005; 54(6): 867 - 874. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response Endocr. Rev., February 1, 2005; 26(1): 1 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Buresi, N. Vergnolle, K. A. Sharkey, C. M. Keenan, P. Andrade-Gordon, G. Cirino, D. Cirillo, M. D. Hollenberg, and W. K. MacNaughton Activation of proteinase-activated receptor-1 inhibits neurally evoked chloride secretion in the mouse colon in vitro Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G337 - G345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K Chan, N. Vergnolle, M. D Hollenberg, and P.-Y. von der Weid Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity J. Physiol., October 15, 2004; 560(2): 563 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Amadesi, J. Nie, N. Vergnolle, G. S. Cottrell, E. F. Grady, M. Trevisani, C. Manni, P. Geppetti, J. A. McRoberts, H. Ennes, et al. Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia J. Neurosci., May 5, 2004; 24(18): 4300 - 4312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Cottrell, S. Amadesi, E. F. Grady, and N. W. Bunnett Trypsin IV, a Novel Agonist of Protease-activated Receptors 2 and 4 J. Biol. Chem., April 2, 2004; 279(14): 13532 - 13539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. OSSOVSKAYA and N. W. BUNNETT Protease-Activated Receptors: Contribution to Physiology and Disease Physiol Rev, April 1, 2004; 84(2): 579 - 621. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
